Biotest AG/ DE0005227235 /
29/03/2023 11:37:42 | Chg. - | Volume | Bid12:19:04 | Ask14:26:12 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
32.00EUR | - | 61 Turnover: 1,952 |
-Bid Size: - | -Ask Size: - | 1.61 bill.EUR | 0.10% | - |
GlobeNewswire
03/12/2021
Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congres...
GlobeNewswire
09/08/2021
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NA...
GlobeNewswire
13/04/2021
ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Inf...
GlobeNewswire
09/12/2020
ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors
GlobeNewswire
10/10/2019
2019 Italian Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares, Vo...
GlobeNewswire
10/10/2019
Canada Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares and Strat...
GlobeNewswire
10/10/2019
United Arab Emirates Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests 2019: Suppli...
GlobeNewswire
10/10/2019
Bahrain Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests, 2019: Infectious and Gen...
GlobeNewswire
10/10/2019
Cyprus Nucleic Acid Testing Market for 100 Assays, 2019: Companies Such as Arca Biopharma, Diadexus ...
GlobeNewswire
10/10/2019
South Korean Nucleic Acid Testing Market for 100 Assays: Five-year test volume and sales forecasts
GlobeNewswire
10/10/2019
2019 Kuwait Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volu...
GlobeNewswire
10/10/2019
Malta Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic ...
GlobeNewswire
22/08/2019
ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®
GlobeNewswire
08/08/2019
ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results
GlobeNewswire
08/07/2019
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
GlobeNewswire
03/05/2019
ADMA Biologics Elects to Draw-Down $27.5 Million in Capital from Existing Perceptive Advisors Credi...
GlobeNewswire
02/05/2019
2019 Nucleic Acid Testing Market Competitive Landscape: Strategic Assessments of Leading Suppliers